• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏收缩力调节:在射血分数降低和永久性心房颤动的心力衰竭患者中的初步经验。

Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.

机构信息

I. Medical Department, University Hospital Mannheim, Theodor-Kutzer-Ufer 1-3, Mannheim D-68167, Germany

I. Medical Department, University Hospital Mannheim, Theodor-Kutzer-Ufer 1-3, Mannheim D-68167, Germany.

出版信息

Europace. 2014 Aug;16(8):1205-9. doi: 10.1093/europace/euu050. Epub 2014 Apr 4.

DOI:10.1093/europace/euu050
PMID:24706089
Abstract

AIMS

Cardiac contractility modulation (CCM) is an electrical therapy for heart failure (HF) with reduced ejection fraction. Sinus rhythm is deemed necessary for effective treatment because the current CCM signal delivery algorithm requires sequential sensing of a p wave, followed by depolarizations at each ventricular lead. In case of atrial fibrillation (AF) CCM is inhibited. This study demonstrates the feasibility of CCM therapy in patients with permanent AF by circumventing the requirement for sensing of a natural p wave.

METHODS AND RESULTS

Five CCM patients with AF received a pacemaker or implantable cardioverter/defibrillator (ICD) upgrade to cardiac resynchronization therapy (CRT) with low atrial sensitivity, which resulted in compulsory atrial stimulation followed by biventricular pacing. The CCM system recognized the atrial stimuli as p waves, which led to CCM signal delivery. Three patients developed permanent AF after a mean follow-up of 40 months of CCM therapy. Two patients had permanent AF at the time of CCM device implantation. All pacemaker or ICD devices were successfully upgraded to CRT. Cardiac resynchronization therapy stimulation rates of ≥96% and CCM stimulation rates between 60% and 95% were achieved. Clinical condition of the patients improved (mean NYHA class -0.7, left ventricular ejection fraction +2%, Minnesota living with HF questionnaire -15.6 points).

CONCLUSION

CCM signal delivery is feasible in HF patients with permanent AF by sequential atrial-ventricular pacing, so that the atrial pacing spike is interpreted as a p wave by the CCM signal delivery algorithm. This experimental approach can be considered in individual cases. A new CCM algorithm, which does not require an atrial electrode, is desirable.

摘要

目的

心脏收缩力调节(CCM)是一种用于射血分数降低的心力衰竭(HF)的电治疗方法。窦性节律被认为是有效治疗的必要条件,因为当前的 CCM 信号传递算法需要依次感测 p 波,然后在每个心室导联进行去极化。在心房颤动(AF)的情况下,CCM 被抑制。本研究通过绕过感测自然 p 波的要求,证明了 CCM 治疗在永久性 AF 患者中的可行性。

方法和结果

5 例 AF 患者接受了起搏器或植入式心脏复律除颤器(ICD)升级为具有低心房感知灵敏度的心脏再同步治疗(CRT),这导致强制心房刺激,随后进行双心室起搏。CCM 系统将心房刺激识别为 p 波,从而导致 CCM 信号传递。在接受 CCM 治疗 40 个月的平均随访后,有 3 例患者发展为永久性 AF。2 例患者在 CCM 设备植入时即患有永久性 AF。所有起搏器或 ICD 设备均成功升级为 CRT。达到了 CRT 刺激率≥96%和 CCM 刺激率在 60%至 95%之间。患者的临床状况得到改善(平均 NYHA 分级-0.7,左心室射血分数+2%,明尼苏达州心力衰竭生活质量问卷-15.6 分)。

结论

通过顺序的房室起搏,CCM 信号传递在永久性 AF 的 HF 患者中是可行的,使得 CCM 信号传递算法将心房起搏尖峰解释为 p 波。这种实验方法可以在个别情况下考虑。需要一种不依赖心房电极的新型 CCM 算法。

相似文献

1
Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.心脏收缩力调节:在射血分数降低和永久性心房颤动的心力衰竭患者中的初步经验。
Europace. 2014 Aug;16(8):1205-9. doi: 10.1093/europace/euu050. Epub 2014 Apr 4.
2
Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).心脏再同步治疗永久性心房颤动患者:来自心力衰竭门诊同步治疗试验(RAFT)的结果。
Circ Heart Fail. 2012 Sep 1;5(5):566-70. doi: 10.1161/CIRCHEARTFAILURE.112.968867. Epub 2012 Aug 14.
3
Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.植入式心脏复律除颤器治疗中房颤的作用:死亡、恰当及不恰当电击的危险因素
J Cardiovasc Electrophysiol. 2013 Oct;24(10):1116-22. doi: 10.1111/jce.12208. Epub 2013 Jul 25.
4
Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.右心室导联位置并不影响心力衰竭伴心房颤动患者心脏再同步治疗的获益。
Europace. 2011 Dec;13(12):1747-52. doi: 10.1093/europace/eur193. Epub 2011 Jun 28.
5
Benefits of upgrading right ventricular to biventricular pacing in heart failure patients with atrial fibrillation.心房颤动心力衰竭患者升级右心室为双心室起搏的益处。
Europace. 2024 Jul 2;26(7). doi: 10.1093/europace/euae179.
6
Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.心脏再同步治疗设备接受者中的心房颤动:随机MASCOT试验的1年结果。
Am Heart J. 2008 Sep;156(3):520-6. doi: 10.1016/j.ahj.2008.04.013. Epub 2008 Jul 7.
7
Cardiac contractility modulation in non-responders to cardiac resynchronization therapy.心脏再同步治疗无反应者的心脏收缩力调制
Europace. 2008 Dec;10(12):1375-80. doi: 10.1093/europace/eun257. Epub 2008 Sep 5.
8
Cardiac resynchronization therapy reduces T-wave alternans in patients with heart failure.心脏再同步治疗可降低心力衰竭患者的 T 波交替。
Europace. 2015 Feb;17(2):281-8. doi: 10.1093/europace/euu258. Epub 2014 Nov 14.
9
Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.心力衰竭患者心脏再同步治疗后心房颤动时心室率控制不良的发生率及临床相关性。
Eur J Heart Fail. 2011 Aug;13(8):868-76. doi: 10.1093/eurjhf/hfr046. Epub 2011 May 10.
10
First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study.通过非兴奋性电流调节心脏收缩力治疗收缩性心力衰竭的首例人体长期试验:一项多中心研究的中期安全性和有效性结果
J Cardiovasc Electrophysiol. 2004 Apr;15(4):418-27. doi: 10.1046/j.1540-8167.2004.03580.x.

引用本文的文献

1
Cardiac contractility modulation in patients with heart failure: The added value of cardiac rehabilitation in identification, management, and follow-up.心力衰竭患者的心脏收缩力调制:心脏康复在识别、管理及随访中的附加价值。
Int J Cardiol Cardiovasc Risk Prev. 2024 May 16;21:200284. doi: 10.1016/j.ijcrp.2024.200284. eCollection 2024 Jun.
2
HF Etiology and cardiac contractility modulation therapy.HF 的病因和心脏收缩力调节治疗。
BMC Cardiovasc Disord. 2024 May 29;24(1):279. doi: 10.1186/s12872-024-03950-8.
3
Cardiac contractility modulation in patients with heart failure - A review of the literature.
心力衰竭患者的心脏收缩力调节——文献综述。
Heart Fail Rev. 2024 May;29(3):689-705. doi: 10.1007/s10741-024-10390-1. Epub 2024 Feb 23.
4
Device therapy for patients with atrial fibrillation and heart failure with preserved ejection fraction.心脏机械装置治疗射血分数保留的心力衰竭合并心房颤动
Heart Fail Rev. 2024 Mar;29(2):417-430. doi: 10.1007/s10741-023-10366-7. Epub 2023 Nov 8.
5
Outcomes of Cardiac Contractility Modulation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.心脏收缩力调节治疗的结果:随机临床试验的系统评价和荟萃分析。
Cardiovasc Ther. 2019 Jun 17;2019:9769724. doi: 10.1155/2019/9769724. eCollection 2019.
6
New Generation Cardiac Contractility Modulation Device-Filling the Gap in Heart Failure Treatment.新一代心脏收缩力调制装置——填补心力衰竭治疗的空白
J Clin Med. 2019 Apr 29;8(5):588. doi: 10.3390/jcm8050588.
7
Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients.心力衰竭患者的心脏收缩力调制与压力反射激活疗法
Curr Heart Fail Rep. 2019 Feb;16(1):38-46. doi: 10.1007/s11897-019-0422-3.
8
[Cardiac contractility modulation for treatment of chronic heart failure].[心脏收缩力调制治疗慢性心力衰竭]
Herzschrittmacherther Elektrophysiol. 2018 Dec;29(4):369-376. doi: 10.1007/s00399-018-0600-0. Epub 2018 Oct 25.
9
Long-term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction.心力衰竭伴射血分数降低患者联合心脏收缩力调制和皮下除颤器治疗的长期结果
Clin Cardiol. 2018 Apr;41(4):518-524. doi: 10.1002/clc.22919. Epub 2018 Apr 26.
10
[Acute and chronic heart failure].[急性和慢性心力衰竭]
Herz. 2017 Nov;42(7):699-712. doi: 10.1007/s00059-017-4613-y.